Background Treatment with inhaled glucocorticoids in combination with long-acting
bronchodilators is recommended in patients with frequent exacerbations of severe chronic …

Background Blood eosinophil counts might predict response to inhaled corticosteroids (ICS)
in patients with chronic obstructive pulmonary disease (COPD) and a history of …

Background Studies demonstrate that the CME/CPD (continuing medical education/continuing
professional development) needs of rural general practitioners (GPs) are unique. Little …

Inhaled corticosteroids (ICSs), together with long-acting bronchodilators, are recommended
for patients with severe chronic obstructive pulmonary disease (COPD) and a history of …

Background Studies in adults and adolescents have demonstrated that tiotropium is efficacious
as an add-on therapy to inhaled corticosteroids (ICSs) with or without other maintenance …

The prostaglandin D 2 (PGD 2 ) receptor, CRTH2, plays a role in allergic airway inflammation.
The efficacy of BI 671800, a CRTH2 antagonist, was assessed in 2 separate trials in …

Background No pharmacological treatments are specifically indicated for painful small fibre
neuropathy (SFN). CONVEY, a phase 2 enriched-enrolment study, evaluated the efficacy …

… of this combination, with and without added ICS, should resolve whether a benefit in
preventing exacerbations can still occur when lung function is optimized across the full 24-h day. …

… h Participants taking >1 TN medication at study entry will be required to gradually titrate down
and discontinue their medications so that they are receiving no more than 1 TN medication …

The WISDOM study (NCT0975195) reported a change in lung function following withdrawal
of fluticasone propionate in patients with severe to very severe COPD treated with tiotropium …